News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,685 Results
Type
Article (40073)
Company Profile (271)
Press Release (661341)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205088)
Career Advice (2020)
Deals (35531)
Drug Delivery (97)
Drug Development (81240)
Employer Resources (172)
FDA (16210)
Job Trends (14913)
News (346454)
Policy (32647)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49776)
ALS (88)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (127)
Approvals (16215)
Artificial intelligence (254)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (279)
Cancer (2263)
Cardiovascular disease (174)
Career advice (1688)
Career pathing (30)
CAR-T (153)
Cell therapy (428)
Cervical cancer (19)
Clinical research (66113)
Collaboration (841)
Compensation (529)
Complete response letters (19)
COVID-19 (2604)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2206)
Decentralized trials (2)
Denatured (20)
Depression (43)
Diabetes (271)
Diagnostics (6390)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86753)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112901)
Executive appointments (729)
FDA (17472)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (753)
Gene editing (106)
Generative AI (19)
Gene therapy (302)
GLP-1 (711)
Government (4429)
Grass and pollen (4)
Guidances (65)
Healthcare (18834)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16540)
IRA (42)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (474)
Leadership (17)
Legal (7944)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13388)
Medtech (13393)
Mergers & acquisitions (19534)
Metabolic disorders (685)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1922)
NextGen: Class of 2025 (6548)
Non-profit (4491)
Now hiring (39)
Obesity (362)
Opinion (208)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57633)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20616)
Phase II (29120)
Phase III (21680)
Pipeline (1200)
Policy (141)
Postmarket research (2564)
Preclinical (8772)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5953)
Recruiting (65)
Regulatory (22348)
Reports (46)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (133)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3629)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (30)
Vaccines (690)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (204)
Last 7 days (902)
Last 30 days (2659)
Last 365 days (33011)
2025 (10727)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38049)
Australia (6232)
California (6146)
Canada (2013)
China (524)
Colorado (268)
Connecticut (274)
Delaware (147)
Europe (81747)
Florida (911)
Georgia (206)
Idaho (58)
Illinois (538)
India (26)
Indiana (308)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (894)
Massachusetts (4580)
Michigan (220)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1727)
New Mexico (28)
New York (1745)
North Carolina (966)
North Dakota (8)
Northern California (2685)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1377)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (23)
South Dakota (1)
Southern California (2309)
Tennessee (101)
Texas (911)
United States (23162)
Utah (180)
Virginia (146)
Washington D.C. (62)
Washington State (554)
West Virginia (3)
Wisconsin (54)
701,685 Results for "calithera biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
Calithera Biosciences, Inc. announced that it intends to hold a special meeting of stockholders on or about June 29, 2023, for the purpose of approving the Company’s Plan of Complete Liquidation and Dissolution.
May 19, 2023
·
6 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Press Releases
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
April 25, 2025
·
4 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Press Releases
Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
March 19, 2025
·
6 min read
Press Releases
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
March 13, 2025
·
1 min read
1 of 70,169
Next
